SMSPHARMA vs TORNTPHARM: Stock Comparison

SMS Pharmaceuticals Limited vs Torrent Pharmaceuticals Limited

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Torrent Pharmaceuticals Limited is the larger company by market capitalisation. SMS Pharmaceuticals Limited shows a lower P/E and lower leverage, while Torrent Pharmaceuticals Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of SMS Pharmaceuticals Limited and Torrent Pharmaceuticals Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, SMSPHARMA is more favourable on 5 of 13 scored metrics and TORNTPHARM on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
TORNTPHARM is the larger company
₹1.66 L Cr vs ₹3,560 Cr
P/E Ratio
SMSPHARMA has a lower P/E
34.95x vs 76.59x
P/B Ratio
SMSPHARMA has a lower P/B
4.54x vs 19.75x
EPS
TORNTPHARM has higher earnings per share
₹63.75 vs ₹11.17
Dividend Yield
TORNTPHARM has a higher dividend yield
0.9% vs 0.1%
Revenue Growth (TTM YoY)
TORNTPHARM has faster revenue growth
41.8% vs -4.1%
EPS Growth (TTM YoY)
SMSPHARMA has faster EPS growth
49.2% vs -21.7%
Qtr Sales Growth
TORNTPHARM has stronger quarterly sales growth
41.8% vs -4.13%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSMSPHARMATORNTPHARM
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSMSPHARMATORNTPHARM
Live Price₹380.75₹4,898.3
Day Change-2.85%-2.41%
Volume1.03 L5.49 L
52-Week High₹447.8₹5,085.8
52-Week Low₹207.99₹3,480.6
Distance from 52W High-14.97%-3.69%

Valuation

MetricSMSPHARMATORNTPHARM
Market Cap₹3,560 Cr₹1.66 L Cr
P/E Ratio34.95x76.59x
P/B Ratio4.54x19.75x
EPS₹11.17₹63.75
Book Value₹81.83₹247.85
Dividend Yield0.1%0.9%

Growth

MetricSMSPHARMATORNTPHARM
Revenue Growth (TTM YoY)-4.1%41.8%
EPS Growth (TTM YoY)49.2%-21.7%
Qtr Sales Growth-4.13%41.8%
Qtr Profit Growth61%-20.6%

Profitability & Leverage

MetricSMSPHARMATORNTPHARM
ROE14.3%16.99%
ROCE13.3%15.2%
Net Margin11.5%15.73%
Operating Margin19.3%25.01%
Debt to Equity0.46x85.45x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSMSPHARMATORNTPHARM
Promoter Holding68.07%68.31%
FII Holding0.65% 0.34 pp15.44% 0.74 pp
DII Holding2.83% 0.19 pp9.83% 0.77 pp
Public Holding28.45% 0.15 pp6.42% 0.03 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SMS Pharmaceuticals Limited and Torrent Pharmaceuticals Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.